This content is machine translated Results from the ICE and SOFT studies Does capecitabine prove effective and who benefits from ovarian suppression? Two studies presented at the 2014 San Antonio Breast Cancer Symposium had been eagerly anticipated: ICE tested adjuvant monochemotherapy with capecitabine in an elderly patient population and SOFT tested ovarian…
